Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
Journal of Virology|April 27, 2026
A single residue in the VP3 capsid protein governs virulence and informs live-attenuated vaccine design for coxsackievirus A6Kexin Liu, Zeyu Liu, Xingyu Yan, et al.
Environmental Science and Pollution Research International|April 3, 2019
Impact of carrier on ammonia and organics removal from zero-discharge marine recirculating aquaculture system with sequencing batch biofilm reactor (SBBR)Jin Li, Weiqiang Zhu, Huiyu Dong, et al.
Journal of Cardiothoracic Surgery|February 3, 2023
Treatments and whole exon sequencing of a case with multiple primary lung cancerGuangyu Bai, Yuan Li, Ying Ji, et al.
Chemsuschem|December 15, 2018
Electrochemical Oxidative C(sp3 )-H/N-H Cross-Coupling for N-Mannich Bases with Hydrogen EvolutionPan Wang, Zhenlin Yang, Ting Wu, et al.
Trends in Pharmacological Sciences|January 8, 2026
Therapeutic antibodies targeting G protein-coupled receptorsQingyuan Xu, Keke Huang, Yibing Shi, et al.
International Journal of Clinical and Experimental Pathology|July 21, 2015
MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathwayXilong Wang, Wenxiu Qiu, Guoqiang Zhang, et al.
Frontiers in Oncology|December 27, 2021
Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based StudySong Wang, Yiyuan Zhang, Fangxu Yin, et al.
Virologica Sinica|July 8, 2026
The C-terminal T234 residue of VP3 is required for KREMEN1 receptor-dependent infectivity and pathogenesis of coxsackieviruses A10 and A8Xingyu Yan, Zeyu Liu, Kexin Liu, et al.
Frontiers in Public Health|October 7, 2022
Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based studyFangxu Yin, Song Wang, Chong Hou, et al.
Emerging Microbes & Infections|April 5, 2022
The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2Xiaolong Tian, Xiaoyi Zhu, Wenping Song, et al.
Pageof 17